NEW YORK (TheStreet) -- Shares of Medtronic (MDT) were gaining 0.2% to $69.09 Monday ahead of the medical appliances and equipment company's fiscal second quarter earnings report before the opening bell on Tuesday.
Analysts expect the company to reported earnings of 96 cents a share and revenue of $4.37 billion for the quarter that ended in October 2014. Medtronic reported earnings of 91 cents a share in the year-ago quarter, beating analysts' estimates of 90 cents a share. The company reported revenue of $4.19 billion in the year-ago quarter, compared to estimates of $4.18 billion.
Medtronic reported earnings of 93 cents a share and revenue of $4.27 billion for the fiscal first quarter, above estimates of 92 cents a share and $4.25 billion.
Must Read: Warren Buffett's 25 Favorite Stocks
TheStreet Ratings team rates MEDTRONIC INC as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:
"We rate MEDTRONIC INC (MDT) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income."